Oxygenated cholesterol sulfate for treating disorders caused by at least one of impaired leptin activity and lipid accumulation disorders

摘要

Methods and compositions are provided for the prevention and / or treatment of symptoms associated with impaired lipid accumulation caused by impaired leptin activity and impaired lipid accumulation. The method includes administering at least one oxygenated cholesterol sulfate (OCS) to the subject having the disorder. The disorder may be acquired or congenital (hereditary). [Selection] Figures 1A-D